The UroLift System is a minimally invasive approach to treating BPH that can be performed as a same-day outpatient procedure
Medical devices company Teleflex has announced the commercial launch of the UroLift System in India for treating Benign Prostatic Hyperplasia (BPH), or enlarged prostate.
The UroLift System is a minimally invasive approach to treating BPH that can be performed as a same-day outpatient procedure. It provides rapid symptom relief for men with BPH and allows a quick recovery time for patients. It is indicated for the treatment of symptoms of an enlarged prostate up to 100 cc in men 50 years and above in India. In India, a prostatic urethral lift like UroLift is an optional therapy and offered as an alternative to patients presenting with moderate-to-severe LUTS who failed to respond to medical management and who are not tolerant or compliant to medical management (GR optional). The UroLif permanent implants, delivered during the procedure, relieve prostate obstruction without heating, cutting, destruction, or removing prostate tissue
Arun Kaushik, Managing Director, South Asia, Teleflex said, “We are excited to launch the UroLift System in India. This technology offers clinical benefits in the minimally invasive treatment of BPH and offers physicians more options in how they treat their patients. Teleflex remains committed to its goal to make the UroLift System the standard of care in the treatment of BPH globally.”
BPH cases with the UroLift system have been performed in Max Super Specialty Hospital (Saket), Medanta The Medicity (Gurugram), Manipal Hospital (HAL Road, Bengaluru,) and CURI Hospital (Chennai).
- Advertisement -